• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Health Sci Rep . Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts

tetano

Editor, Senior Moderator
Health Sci Rep


. 2021 Jan 15;4(1):e233.
doi: 10.1002/hsr2.233. eCollection 2021 Mar.
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts


Einar Kristian Borud[SUP] 1 2 [/SUP], Espen Rostrup Nakstad[SUP] 3 [/SUP], Siri Eldevik H?berg[SUP] 4 [/SUP], Andreas Lind[SUP] 3 [/SUP], Elin Anita Fadum[SUP] 1 [/SUP], Arne Michael Taxt[SUP] 3 [/SUP], Anneke Steens[SUP] 4 [/SUP], Gaute Eriksen Gjein[SUP] 1 [/SUP], Magne Wiken Sunde[SUP] 1 [/SUP], Petter Iversen[SUP] 1 [/SUP], Marius Svanevik[SUP] 1 [/SUP], Babar Mushtaq Ahmad[SUP] 1 [/SUP], Thomas Waldow[SUP] 1 [/SUP], Arne Johan Norheim[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: Accurate estimates of SARS-CoV-2 infection in different population groups are important for the health authorities. In Norway, public infection control measures have successfully curbed the pandemic. However, military training and service are incompatible with these measures; therefore extended infection control measures were implemented in the Norwegian Armed Forces. We aimed to describe these measures, discuss their value, and investigate the polymerase chain reaction (PCR) prevalence and seroprevalence of SARS-CoV-2, as well as changes in antibody titer levels over the 6-week military training period in a young, asymptomatic population of conscripts.
Methods: In April 2020, 1170 healthy conscripts (median age 20 years) enrolled in military training. Extended infection control measures included a pre-enrollment telephone interview, self-imposed quarantine, questionnaires, and serial SARS-CoV-2 testing. At enrollment, questionnaires were used to collect information on symptoms, and SARS-CoV-2 rapid antibody testing was conducted. Serial SARS-CoV-2 PCR and serology testing were used to estimate the prevalence of confirmed SARS-CoV-2 and monitor titer levels at enrollment, and 3 and 6 weeks thereafter.
Results: At enrollment, only 0.2% of conscripts were SARS-CoV-2 PCR-positive, and seroprevalence was 0.6%. Serological titer levels increased nearly 5-fold over the 6-week observation period. Eighteen conscripts reported mild respiratory symptoms during the 2 weeks prior to enrollment (all were PCR-negative; one was serology-positive), whereas 17 conscripts reported respiratory symptoms and nine had fever at enrollment (all were PCR- and serology-negative).
Conclusions: The prevalence of SARS-CoV-2 was less than 1% in our sample of healthy Norwegian conscripts. Testing of asymptomatic conscripts seems of no value in times of low COVID-19 prevalence. SARS-CoV-2 antibody titer levels increased substantially over time in conscripts with mild symptoms.

Keywords: Armed Forces; COVID‐19; SARS‐CoV‐2; adolescents; conscripts; coronavirus; prevalence; serological analyses; serology; youths.
 
Back
Top Bottom